Robot-Assisted Gait Training vs NMES in Parkinson's Disease
NCT: NCT07589296 · RECRUITING
Brief Summary
This prospective, randomized, assessor-blinded clinical trial aims to compare the effects of robot-assisted gait training and quadriceps neuromuscular electrical stimulation (NMES) when added to a standard exercise rehabilitation program in patients with Parkinson disease. Participants will be randomly assigned to two parallel groups. Both groups will receive a standard rehabilitation program, while one group will additionally undergo robot-assisted gait training and the other group will receive quadriceps NMES. The interventions will be administered five days per week for six weeks. Clinical outcomes, including balance, functional mobility, gait performance, and disease severity, will be evaluated at baseline, post-treatment, and follow-up (week 14). In addition, ultrasound-based assessments of quadriceps muscle thickness and cross-sectional area will be performed to investigate muscle adaptations. The results of this study are expected to provide comparative evidence regarding the effectiveness of these two rehabilitation approaches and contribute to optimizing rehabilitation strategies in Parkinson disease.
Frequently Asked Questions
What is Robot-Assisted Gait Training vs NMES in Parkinson's Disease?
Robot-Assisted Gait Training vs NMES in Parkinson's Disease is a clinical trial registered under NCT07589296. Current status: RECRUITING.
What is the status of NCT07589296?
The current status of NCT07589296 (Robot-Assisted Gait Training vs NMES in Parkinson's Disease) is: RECRUITING.
When did Robot-Assisted Gait Training vs NMES in Parkinson's Disease start?
Robot-Assisted Gait Training vs NMES in Parkinson's Disease started on 2026-04-15.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.